Search

everythinglearnresearchcommunity

for

Search:↓

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Lavandula stoechas helps wounds heal faster in diabetic and non-diabetic rats.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Testosterone increases sexual behavior in female capuchin monkeys.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Endovascular repair and open surgery for abdominal aortic aneurysms both result in a temporary decline in physical health, with no significant mental health difference, and a return to near normal health in 90 days.

Adequate vitamin D might lower, and high hair chromium might increase DNA damage in obese women.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

People with alopecia areata have higher insulin resistance.